Regulating centrosome homeostasis through the UPS
通过 UPS 调节中心体稳态
基本信息
- 批准号:9178269
- 负责人:
- 金额:$ 18.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-01 至 2018-06-30
- 项目状态:已结题
- 来源:
- 关键词:26S proteasomeAffinity ChromatographyBindingBinding ProteinsBiochemicalBiological AssayBiologyBoxingCUL1 geneCancer BiologyCell CycleCell Cycle ProgressionCell LineCell physiologyCellsCentriolesCentrosomeChromosomal InstabilityCiliaClinicalComplexCullin ProteinsDegradation PathwayDevelopmentDiseaseDrug TargetingDwarfismEnzymesF Box DomainF-Box MotifsF-Box ProteinsFamilyGrantHereditary DiseaseHomeostasisIL27RA geneLaboratoriesLeadLigaseLysineMalignant NeoplasmsMalignant neoplasm of brainMammalsMass Spectrum AnalysisMediatingMicrocephalyMolecularNeuronsOrangesOrphanPhasePhosphorylationPlayPolyubiquitinPopulation ResearchPost-Translational Protein ProcessingProcessProteinsProteolysisProteomicsPublishingRecruitment ActivityRegulationResearchResearch Project GrantsResourcesRoleSignal Transduction PathwaySpecificitySystemTechniquesThalidomideUbiquitinUbiquitin-Conjugating EnzymesUbiquitin-mediated Proteolysis PathwayUbiquitinationbasebeta-Transducin Repeat-Containing Proteinsciliopathycyclin Ffight againstgenetic regulatory proteinhuman diseaseinhibitor/antagonistlenalidomidemulticatalytic endopeptidase complexneurodevelopmentneuron developmentnovelprogramsprotein complexprotein degradationprotein protein interactionreceptorresponsescaffoldubiquitin ligaseubiquitin-protein ligaseweb-accessible
项目摘要
PROJECT SUMMARY/ABSTRACT
Ubiquitin-mediated proteolysis regulates the degradation of numerous proteins, thereby
controlling many cellular processes, including cell cycle progression, signal transduction
pathways, differentiation, and the centrosome duplication cycle. Much of the specificity
inherent in the ubiquitination process is mediated by the E3 ubiquitin ligases, which bind
selectively to, and recruit, the chosen substrate to the ubiquitin-conjugating enzyme. Notably,
the majority of ubiquitin ligases are considered “orphan”, because their substrates have not yet
been identified. Several ubiquitin ligases localize to the centrosome and control the
ubiquitination and subsequent proteasomal degradation of critical centriole duplication factors,
such as CP110, PLK4, and SAS6 (by SCF-Cyclin F, SCF-βTrCP, and APC/C-Cdh1, respectively).
Furthermore, ubiquitin ligases also control additional centrosomal functions, such as centriole
separation (through the SCF-βTrCP-mediated degradation of Cep68). Our preliminary results
show that additional “orphan” E3 ligase complexes reside at the centrosome, and that several
centrosomal proteins are degraded by the ubiquitin system during specific phases of the cell
cycle. We propose a project systematically exploring the regulation of the centrosome cycle by
the ubiquitin-proteasome system. We will use proteomic techniques to identify novel
substrates of centrosomal E3 ligases (specific AIM 1) and will validate and biochemically
characterize the most biologically significant substrates identified under AIM 1 (specific AIM 2).
We will make our analysis of E3 ubiquitin ligases and centrosome interactors available as a
web-accessible resource. Centrosome amplification is a common feature of the large majority of
cancers and can result in chromosome instability. Furthermore, centrosome abnormalities are
also associated with genetic disorders of neurons and cellular cilia. Therefore, the information
gained from the proposed studies is expected to be of direct relevance to our understanding of
cancer biology and other human diseases such as ciliopathies and neuronal development
disorders.
项目摘要/摘要
泛素介导的蛋白质降解调节多种蛋白质的降解,从而
控制许多细胞过程,包括细胞周期进程、信号转导
途径、分化和中心体复制周期。大部分的特定性
泛素化过程中固有的是由E3泛素连接酶介导的,它结合
选择性地将所选择的底物招募到泛素结合酶。值得注意的是,
大多数泛素连接酶被认为是“孤儿”,因为它们的底物还没有
已被确认身份。几种泛素连接酶定位于中心体并控制
关键中心粒复制因子的泛素化和随后的蛋白酶体降解,
例如CP110、Plk4和SaS6(分别通过SCF-Cyclin F、SCF-βTrCP和APC/C-CDH1)。
此外,泛素连接酶还控制中心粒等额外的中心体功能。
分离(通过SCF-βTrCP介导的Cep68降解)。我们的初步结果
显示另外的孤立的E3连接酶复合体驻留在中心体,以及几个
中心体蛋白在细胞的特定阶段被泛素系统降解。
周而复始。我们提出了一个项目,系统地探索中心体周期的调节,通过
泛素-蛋白酶体系统。我们将使用蛋白质组学技术来鉴定新的
中心体E3连接酶底物(特异性AIM 1),并将验证和生化
确定AIM 1(特定AIM 2)中确定的最具生物学意义的底物的特征。
我们将把我们对E3泛素连接酶和中心体相互作用的分析作为一种
可通过Web访问的资源。中心体扩增是绝大多数人的共同特征
癌症,并可能导致染色体不稳定。此外,中心体异常是
也与神经元和细胞纤毛的遗传障碍有关。因此,这些信息
从拟议的研究中获得的成果预计将与我们对
癌症生物学和其他人类疾病,如纤毛疾病和神经元发育
精神错乱。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHELE PAGANO其他文献
MICHELE PAGANO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHELE PAGANO', 18)}}的其他基金
Regulation of the cell proliferation by CRL ubiquitin ligases-diversity supplement
CRL 泛素连接酶-多样性补充对细胞增殖的调节
- 批准号:
10594747 - 财政年份:2020
- 资助金额:
$ 18.43万 - 项目类别:
Regulation of the cell proliferation by CRL ubiquitin ligases
CRL 泛素连接酶对细胞增殖的调节
- 批准号:
10590637 - 财政年份:2020
- 资助金额:
$ 18.43万 - 项目类别:
Regulation of the cell proliferation by CRL ubiquitin ligases
CRL 泛素连接酶对细胞增殖的调节
- 批准号:
10725087 - 财政年份:2020
- 资助金额:
$ 18.43万 - 项目类别:
Regulation of the cell proliferation by CRL ubiquitin ligases
CRL 泛素连接酶对细胞增殖的调节
- 批准号:
10379088 - 财政年份:2020
- 资助金额:
$ 18.43万 - 项目类别:
F-box proteins: deregulated cell cycle control and proteolysis in cancer
F-box 蛋白:癌症中细胞周期控制和蛋白水解失调
- 批准号:
8761279 - 财政年份:2013
- 资助金额:
$ 18.43万 - 项目类别:
Role of the SCF/FBX011 ubiquitin ligase in the control of cell proliferation
SCF/FBX011 泛素连接酶在细胞增殖控制中的作用
- 批准号:
8325492 - 财政年份:2011
- 资助金额:
$ 18.43万 - 项目类别:
Role of the SCF/Fbxo15 ubiquitin ligase in stem cells and cancer biology
SCF/Fbxo15 泛素连接酶在干细胞和癌症生物学中的作用
- 批准号:
8274655 - 财政年份:2011
- 资助金额:
$ 18.43万 - 项目类别:
Role of the SCF/Fbxo15 ubiquitin ligase in stem cells and cancer biology
SCF/Fbxo15 泛素连接酶在干细胞和癌症生物学中的作用
- 批准号:
8168513 - 财政年份:2011
- 资助金额:
$ 18.43万 - 项目类别:
Role of the SCF/FBX011 ubiquitin ligase in the control of cell proliferation
SCF/FBX011 泛素连接酶在细胞增殖控制中的作用
- 批准号:
8513435 - 财政年份:2011
- 资助金额:
$ 18.43万 - 项目类别:
Role of the SCF/FBX011 ubiquitin ligase in the control of cell proliferation
SCF/FBX011 泛素连接酶在细胞增殖控制中的作用
- 批准号:
8152909 - 财政年份:2011
- 资助金额:
$ 18.43万 - 项目类别:
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 18.43万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 18.43万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 18.43万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 18.43万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 18.43万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 18.43万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 18.43万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 18.43万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 18.43万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 18.43万 - 项目类别:
Collaborative Research and Development Grants